Organogenesis Holdings Inc.
US ˙ NasdaqCM ˙ US68621F1021

SecurityORGO / Organogenesis Holdings Inc.
InstitutionSignaturefd, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Signaturefd, Llc closes position in ORGO / Organogenesis Holdings Inc.

On April 7, 2026 - Signaturefd, Llc filed a 13F-HR form disclosing ownership of 0 shares of Organogenesis Holdings Inc. (US:ORGO) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 182 shares of Organogenesis Holdings Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 0 -100.00 0
2026-01-20 2025-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 182 0 0.00 1 0.0000
2025-10-21 2025-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 182 0 0.00 1 0.0000
2025-07-16 2025-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 182 -235 -56.35 1 -100.00 0.0000
2025-05-02 2025-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 417 235 129.12 2 0.0000
2025-02-10 2024-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 182 0 0.00 1 0.0000
2024-10-21 2024-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 182 -19 -9.45 1 0.0000
2024-07-29 2024-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 201 201 1 0.0000
2024-05-03 2024-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 0 -700 -100.00 0 -100.00
2024-02-01 2023-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 700 700 3 0.0001
2023-11-03 2023-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 0 -713 -100.00 0 -100.00
2023-08-01 2023-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 713 -647 -47.57 2 0.00 0.0001
2023-04-28 2023-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 1,360 151 12.49 3 -33.33 0.0001
2023-01-30 2022-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 1,209 536 79.64 3 50.00 0.0001
2022-11-08 2022-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 673 673 2 0.0001
2022-01-25 2021-12-31 13F ORGANOGENESIS HLDGS COM 68621F102 0 -200 -100.00 0 -100.00
2021-10-28 2021-09-30 13F ORGANOGENESIS HLDGS COM 68621F102 200 200 3 0.0001
2020-07-30 2020-06-30 13F ORGANOGENESIS HLDGS COM 68621F102 0 -150 -100.00 0 0.0000
2020-04-23 2020-03-31 13F ORGANOGENESIS HLDGS COM 68621F102 150 150 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.